首页> 美国卫生研究院文献>other >Regulation of Heat Shock Proteins 27 and 70 p-Akt/p-eNOS and MAPKs by Naringin Dampens Myocardial Injury and Dysfunction In Vivo after Ischemia/Reperfusion
【2h】

Regulation of Heat Shock Proteins 27 and 70 p-Akt/p-eNOS and MAPKs by Naringin Dampens Myocardial Injury and Dysfunction In Vivo after Ischemia/Reperfusion

机译:柚皮苷调节热休克蛋白27和70p-Akt / p-eNOS和MAPKs抑制缺血/再灌注后的心肌损伤和体内功能障碍

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Naringin has antioxidant properties that could improve redox-sensitive myocardial ischemia reperfusion (IR) injury. This study was designed to investigate whether naringin restores the myocardial damage and dysfunction in vivo after IR and the mechanisms underlying its cardioprotective effects. Naringin (20–80 mg/kg/day, p.o.) or saline were administered to rats for 14 days and the myocardial IR injury was induced on 15th day by occluding the left anterior descending coronary artery for 45 min and subsequent reperfusion for 60 min. Post-IR rats exhibited pronounced cardiac dysfunction as evidenced by significantly decreased mean arterial pressure, heart rate, +LVdP/dt max (inotropic state), -LVdP/dt max (lusitropic state) and increased left ventricular end diastolic pressure as compared to sham group, which was improved by naringin. Further, on histopathological and ultrastructural assessments myocardium and myocytes appeared more normal in structure and the infarct size was reduced significantly in naringin 40 and 80 mg/kg/day group. This amelioration of post-IR-associated cardiac injury by naringin was accompanied by increased nitric oxide (NO) bioavailability, decreased NO inactivation to nitrotyrosine, amplified protein expressions of Hsp27, Hsp70, β-catenin and increased p-eNOS/eNOS, p-Akt/Akt, and p-ERK/ERK ratio. In addition, IR-induced TNF-α/IKK-β/NF-κB upregulation and JNK phosphorylation were significantly attenuated by naringin. Moreover, western blotting and immunohistochemistry analysis of apoptotic signaling pathway further established naringin cardioprotective potential as it upregulated Bcl-2 expression and downregulated Bax and Caspase-3 expression with reduced TUNEL positivity. Naringin also normalized the cardiac injury markers (lactate dehydrogenase and creatine kinase-MB), endogenous antioxidant activities (superoxide dismutase, reduced glutathione and glutathione peroxidase) and lipid peroxidation levels. Thus, naringin restored IR injury by preserving myocardial structural integrity and regulating Hsp27, Hsp70, p-eNOS/p-Akt/p-ERK signaling and inflammatory response.
机译:柚皮苷具有抗氧化特性,可以改善对氧化还原敏感的心肌缺血再灌注(IR)损伤。这项研究旨在调查柚皮苷是否可以在IR后体内恢复心肌损伤和功能障碍,以及其心脏保护作用的潜在机制。给大鼠服用柚皮苷(20–80 mg / kg /天,口服)或生理盐水14天,并在第15天通过闭塞左冠状动脉前降支45诱发心肌IR损伤3分钟,然后再灌注60分钟。与假手术相比,IR后大鼠表现出明显的心脏功能障碍,这可以通过平均动脉压,心率,+ LVdP / dt max(正性肌力),-LVdP / dt max(负性肌力)和左心室舒张末期压升高明显降低来证明。小组,通过柚皮苷改善。此外,在组织病理学和超微结构评估中,柚皮苷40和80 mg / kg / day组心肌和心肌细胞的结构似乎更正常,梗死面积明显减少。柚皮苷减轻IR相关的心脏损伤的过程包括增加一氧化氮(NO)的生物利用度,减少NO对硝基酪氨酸的失活,Hsp27,Hsp70,β-catenin的蛋白表达增强以及p-eNOS / eNOS,p- Akt / Akt和p-ERK / ERK比率。此外,柚皮苷显着减弱了IR诱导的TNF-α/IKK-β/NF-κB上调和JNK磷酸化。此外,凋亡信号通路的蛋白质印迹和免疫组织化学分析进一步建立了柚皮苷的心脏保护潜力,因为它可以上调Bcl-2表达,下调Bax和Caspase-3表达,而TUNEL阳性率却降低。柚皮苷还使心脏损伤标志物(乳酸脱氢酶和肌酸激酶-MB),内源性抗氧化剂活性(超氧化物歧化酶,谷胱甘肽和谷胱甘肽过氧化物酶减少)和脂质过氧化水平正常化。因此,柚皮苷通过保持心肌结构完整性并调节Hsp27,Hsp70,p-eNOS / p-Akt / p-ERK信号传导和炎症反应而恢复了IR损伤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号